<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There are significant associations between moderate increases in serum <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and three <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e>: <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> and <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo>, and <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>An association between the presence of <z:hpo ids='HP_0004953'>abdominal aortic aneurysm</z:hpo> and elevated <z:chebi fb="0" ids="17230">homocysteine</z:chebi> plasma levels has been indicated </plain></SENT>
<SENT sid="2" pm="."><plain>Although <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0000822'>systemic hypertension</z:hpo> is the most common factor predisposing the aorta to dissection, homocysteinemia has never been known as the risk for <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> except for that with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Homocysteinemia is suggested to be the risk for <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> and spontaneous cervical <z:e sem="disease" ids="C0002949" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">artery dissection</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Reduced fibrillin-1 deposition into the extracellular matrix is found not only in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> but also in isolated <z:hpo ids='HP_0002631'>ascending aortic aneurysm</z:hpo> and dissection </plain></SENT>
<SENT sid="5" pm="."><plain>The reduced matrix deposition produces a mild form of <z:mp ids='MP_0000746'>weakness</z:mp> of elastic tissue, which predisposes to <z:hpo ids='HP_0002631'>ascending aortic aneurysm</z:hpo> and dissection in patients who do not have the <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The defect in fibrillin-1 leads to: (1) formation of elastin that is abnormally aggregated and more easily degraded by matrix metalloproteinases than is <z:mpath ids='MPATH_458'>normal</z:mpath> elastin; (2) upregulation of the synthesis of matrix metalloproteinases; (3) progressive destruction of connective tissue by these enzymes; (4) development of thoracic <z:hpo ids='HP_0004942'>aortic aneurysms</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="17230">Homocysteine</z:chebi> causes premature breakdown in the arterial elastic fibers by activation of the elastolytic activities </plain></SENT>
<SENT sid="8" pm="."><plain>Irreversible homocysteinylation of long-lived proteins should lead to cumulative damage and progressive clinical manifestations, and fibrillin-1 is seen as the paradigm of extracellular connective tissue proteins that are specially susceptible to <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (and presumably <z:chebi fb="0" ids="17230">homocysteine</z:chebi> thiolactone) attack </plain></SENT>
<SENT sid="9" pm="."><plain>The authors hereupon propose a novel hypothesis that <z:chebi fb="0" ids="17230">homocysteine</z:chebi> plays an important role in development of <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> and that homocysteinemia is one of the risk factors for <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> </plain></SENT>
</text></document>